Meyer Burger Technology has successfully issued green senior unsecured guaranteed convertible bonds due 2029 in the aggregate amount of EUR 216.3 m. The bonds were placed in a private placement with a coupon of 3.75% per annum. The
Tags :Stefan Oesterhelt
Banking & Finance
Corporate
Tech
Homburger: wefox revolving credit facility and a Series D extension
Wefox the Berlin-based insurtech company, has secured a EUR 50 m revolving credit facility arranged by J.P. Morgan Securities and Barclays Bank, following a USD 55 m second close in its Series D that was completed
Homburger acted as counsel to Swarovski International Holding in connection with the extension of its revolving credit facility, arranged by, amongst others, UBS Switzerland AG and Credit Suisse (Switzerland). Homburger advised Swarovski International Holding and
Homburger advised the initial purchasers and arrangers in connection with CABB group’s EUR 250 million senior secured floating rate notes and EUR 420 million 8.75% senior secured fixed rate notes due 2028 and a new EUR 110 million revolving
Siegfried and DiNAQOR entered into an agreement relating to the acquisition by Siegfried of a 95% stake in DiNAQOR DiNAMIQS, a Swiss-based biotechnology company focused on the development and manufacturing of viral vectors for cell and
Homburger acted as counsel to Fluence in connection with certain financing aspects of the acquisition of Nispera. Headquartered in Arlington, USA, Fluence is a global provider of energy storage products, services and digital applications for
Homburger acted as counsel to GTT Communications on certain financing aspects related to its recent restructuring efforts. Homburger acted as counsel to GTT Communications in connection with a term loan credit agreement with Wilmington Savings
Valaris Limited and its wholly-owned subsidiary, Valaris Finance Company, closed the private placement of USD 700 million in aggregate principal amount of 8.375% senior secured second lien notes due 2030 and a senior secured first lien five-year credit
Homburger and Baker McKenzie have acted as advisors in connection with Comet Holding‘s new CHF 60 million multicurrency revolving credit facility agreement. Comet is a globally leading Swiss technology company in the plasma control and
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
